ERBB2 and breast cancer: In QLQ-C30 functional scales, hormonal (S.E = 0.53, OR = 3.7, p = 0.01) and HER2-targeted (S.E = 1.13, OR = 10.2, p = 0.04) therapies were positive predictors of good QOL in BC patients.